Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 25, 2009Clinical Cancer Research

Neuropilins in Tumor Biology

View Full Paper
Ask AI
Bookmark
Share

Authors

ABAnil BagriUniversity of Maryland, BaltimoreMTMarc Tessier‐LavigneRockefeller UniversityRWRyan J. WattsDenali Therapeutics (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bagri et al. (2009) studied this question.

synapsesocial.com/papers/6a89182a37d2918d2e1260cchttps://doi.org/10.1158/1078-0432.ccr-08-0563
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Targeting lymphangiogenesis to prevent tumour metastasis2006 · 166 citations
  2. 2Separating genetic and hemodynamic defects in neuropilin 1 knockout embryos2008 · 116 citations
  3. 3Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype2004 · 288 citations
  4. 4Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration2006 · 301 citations
  5. 5Therapeutic Targeting of Neuropilin-2 on Colorectal Carcinoma Cells Implanted in the Murine Liver2008 · 159 citations